Construction of a bispecific antisense oligonucleotide containing multiple binding sites for the treatment of hormone insensitive prostate tumors-Reference-Cited by-同舟云学术

Construction of a bispecific antisense oligonucleotide containing multiple binding sites for the treatment of hormone insensitive prostate tumors

Published:2005-01 Issue:5 Volume:65 Page:905-907
ISSN:0306-9877
Container-title:Medical Hypotheses
language:en
Short-container-title:Medical Hypotheses

Author:

Rubenstein Marvin,Tsui Paulus,Guinan Patrick

Publisher

Elsevier BV

Subject

General Medicine

Reference9 articles.

1. Inhibition of Rous sarcoma virus replication and transformation by a specific deoxynucleotide;Zamecnik;Proc Natl Acad Sci USA,1979

2. A review of antisense oligonucleotides in the treatment of human disease;Rubenstein;Drug Future,2004

3. Growth factor deprivation therapy utilizing antisense oligonucleotides;Rubenstein;DN&P,1994

4. Antisense oligonucleotide intralesional therapy for human PC-3 prostate tumors carried in athymic nude mice;Rubenstein;J Surg Oncol,1996

5. Novel bispecific antisense oligonucleotides inhibiting both bcl-2 and bcl-xl expression induce apoptosis and enhance chemosensitivity in human androgen-independent prostate cancer cells;Yamanaka;Proc Am Assoc Cancer Res,2004

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Differentiated prostatic antigen expression in LNCaP cells following treatment with bispecific antisense oligonucleotides directed against BCL-2 and EGFR;Medical Oncology;2011-05-15

2. Bax expression remains unchanged following antisense treatment directed against BCL-2;Medical Oncology;2010-04-27

3. Increased prostate-specific membrane antigen expression in LNCaP cells following treatment with bispecific antisense oligonucleotides directed against bcl-2 and EGFR;Medical Oncology;2009-11-24

4. Treatment of prostate and breast tumors employing mono- and bi-specific antisense oligonucleotides targeting apoptosis inhibitory proteins clusterin and bcl-2;Medical Oncology;2009-06-16

5. Multigene targeting of signal transduction pathways for the treatment of breast and prostate tumors;Medical Oncology;2008-08-07